VOLITIONRX LTD — Director's Dealing 2014

Jan 27, 2014

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2013-12-31

Reporting Person: Reynolds Cameron John (Director, President & CEO, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	202344	Direct
Common Stock	2042088	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option	$3	2015-05-25	Common Stock (20000)	20000	Direct
Option	$3	2015-11-25	Common Stock (20000)	20000	Direct
Option	$4	2016-05-25	Common Stock (20000)	20000	Direct
Option	$4	2016-11-25	Common Stock (20000)	20000	Direct
Option	$5	2017-05-25	Common Stock (20000)	20000	Direct
Option	$5	2017-11-25	Common Stock (20000)	20000	Direct
Warrant	$2.6	2016-05-10	Common Stock (1172)	1172	Direct

Footnotes

F1: The shares are held by Concord International, Inc. in trust. Mr. Reynolds is a potential beneficiary of the trust, however, any distribution will be determined by the trustee and there is no actual entitlement to a distribution of the shares.